Company shares last traded at $54.12 a great deal lower than $60.57, the stock’s 50 day moving average and a bit lower than the 200 day moving average of $54.44. The 50 day moving average went down $-6.45 or -10.65% and the 200 day average went down $-0.32 or -0.58%. Trading was light with 194K shares changing hands on Tuesday. Volume was down 26.45% under the stocks average daily volume. Investors are more bullish on ProShares Ultra Nasdaq Biotechn recently if you watch the downtick in short interest. The firm saw a fall in short interest of -31.47% as of the latest report on October 13, 2017. Short shares decreased from 114,787 to 78,667 over that period.
A few notable investment firms have updated their holdings. As of quarter end Cutler Group LP had acquired 19,600 shares growing its stake by 19,600.0%. The value of the investment in BIB increased from $5,000 to $20,000 a change of 300.0% quarter to quarter. As of the end of the quarter Advisory Services Network, LLC had sold a total of 44 shares trimming its holdings by 4.4%. The value of the investment in (BIB) went from $54,000 to $59,000 a change of $5,000 quarter over quarter.
Creative Planning augmented its ownership by buying 2,138 shares an increase of 69.1% from 06/30/2017 to 09/30/2017. Creative Planning controls 5,234 shares valued at $321,000. The value of the position overall is up by 94.5%. As of the end of the quarter Private Capital Advisors, Inc. had disposed of a total of 10,004 shares trimming its position 50.0%. The value of the company’s investment in ProShares Ultra Nasdaq Biotechn decreased from $1,068,000 to $612,000 decreasing 42.7% for the reporting period.